{"database": "lobbying", "table": "lobbying_activities", "rows": [[1908482, "cce232f3-1c49-449b-a1db-bf6adb4c81d8", "Q4", "VAN SCOYOC ASSOCIATES", 39837, "AMERICAN CLINICAL LABORATORY ASSOCIATION", 2016, "fourth_quarter", "BUD", "FDA Regulation of Clinical tests as follows:\n\nH.R.5054/S.2956, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FY2017 \n\nPublic Law 114-223, Continuing Appropriations and Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, FY2017, and Zika Response and Preparedness Act\n\nPublic Law 114-254, Further Continuing and Security Assistance Appropriations Act, 2017", "HOUSE OF REPRESENTATIVES,SENATE", 50000, null, 0, 0, "2016-12-30T20:36:46.493000-05:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1908482"], "units": {}, "query_ms": 92.47177303768694, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}